Z. Babar and Areesha Babar, “FDA’s New Approval: Kisunla (Donanemab-Azbt) - A Major Breakthrough in Alzheimer’s Care”, J Pak Med Assoc, vol. 75, no. 07, pp. 1156–1156, Jul. 2025.